|
|
Volumn 32, Issue 8, 2000, Pages 2787-2788
|
|
Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients
a
b
a
b
a
b
a
d
a,c
d
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN;
AZATHIOPRINE;
CERIVASTATIN;
CYCLOSPORIN A;
LIPID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
ADULT;
CARDIOVASCULAR DISEASE;
CELL ACTIVATION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFECT;
ENDOTHELIUM CELL;
FEMALE;
GENETIC PREDISPOSITION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LIPID BLOOD LEVEL;
LIPID COMPOSITION;
LIPID PEROXIDATION;
MALE;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
RECIPIENT;
THROMBOCYTE ACTIVATION;
APOLIPOPROTEINS;
CHOLESTEROL;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIPIDS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
PYRIDINES;
TRIGLYCERIDES;
|
|
EID: 0034533628
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01886-8 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (7)
|
